- Home
- SPB vs AMLX Comparison
SPB vs AMLX Comparison
Compare SPB & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPB | AMLX |
|---|---|---|
| Founded | 1906 | 2014 |
| Country | United States | United States |
| Employees | 3000 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SPB | AMLX |
|---|---|---|
| Price | $82.71 | $16.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $82.40 | $21.56 |
| AVG Volume (30 Days) | 228.0K | ★ 1.0M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | N/A | ★ 65.46 |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $3,802,100,000.00 | $380,786,000.00 |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $1.85 | N/A |
| P/E Ratio | $65.93 | ★ N/A |
| Revenue Growth | 20.86 | ★ 1612.94 |
| 52 Week Low | $49.99 | $4.41 |
| 52 Week High | $85.49 | $18.61 |
Technical Indicators
Market Signals| Indicator | SPB | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 56.23 | 53.32 |
| Support Level | $73.37 | $12.29 |
| Resistance Level | $85.49 | $17.22 |
| Average True Range (ATR) | 2.18 | 0.82 |
| MACD | -0.38 | -0.20 |
| Stochastic Oscillator | 58.17 | 35.46 |
Price Performance
Historical ComparisonAbout SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.